SARITAŞ, A. G. Et Al. 2019. Effect of neoadjuvant chemotherapy on estrogen receptor, progesterone receptor, Cerb-B-2, vascular endothelial growth factor and Ki-67 in patients with locally advanced breast cancer. CUKUROVA MEDICAL JOURNAL , vol.44, no.1 , 226-231.

SARITAŞ, A. G., YALAV, O., Kekec, Y., SAKMAN, G., BAĞIR KILIÇ, E., ZORLUDEMİR, S., ... ERGİN, M.(2019). Effect of neoadjuvant chemotherapy on estrogen receptor, progesterone receptor, Cerb-B-2, vascular endothelial growth factor and Ki-67 in patients with locally advanced breast cancer. CUKUROVA MEDICAL JOURNAL , vol.44, no.1, 226-231.

SARITAŞ, AHMET Et Al. "Effect of neoadjuvant chemotherapy on estrogen receptor, progesterone receptor, Cerb-B-2, vascular endothelial growth factor and Ki-67 in patients with locally advanced breast cancer," CUKUROVA MEDICAL JOURNAL , vol.44, no.1, 226-231, 2019

SARITAŞ, AHMET G. Et Al. "Effect of neoadjuvant chemotherapy on estrogen receptor, progesterone receptor, Cerb-B-2, vascular endothelial growth factor and Ki-67 in patients with locally advanced breast cancer." CUKUROVA MEDICAL JOURNAL , vol.44, no.1, pp.226-231, 2019

SARITAŞ, A. G. Et Al. (2019) . "Effect of neoadjuvant chemotherapy on estrogen receptor, progesterone receptor, Cerb-B-2, vascular endothelial growth factor and Ki-67 in patients with locally advanced breast cancer." CUKUROVA MEDICAL JOURNAL , vol.44, no.1, pp.226-231.

@article{article, author={AHMET GÖKHAN SARITAŞ Et Al. }, title={Effect of neoadjuvant chemotherapy on estrogen receptor, progesterone receptor, Cerb-B-2, vascular endothelial growth factor and Ki-67 in patients with locally advanced breast cancer}, journal={CUKUROVA MEDICAL JOURNAL}, year=2019, pages={226-231} }